BACKGROUND: Prenatal alcohol exposure (PAE) causes long-term growth and neurodevelopmental deficits that are worsened by maternal iron deficiency (ID). In our preclinical rat model, PAE causes fetal anemia, brain ID, and elevated hepatic iron via increased maternal and fetal hepcidin synthesis. These changes are normalized by a prenatal iron-fortified (IF) diet. Here, we hypothesize that iron status and PAE dysregulate the major upstream pathways that govern hepcidin production-EPO/BMP6/SMAD and IL-6/JAK2/STAT3. METHODS: Pregnant, Long Evans rat dams consumed ID (2 to 6 ppm iron), iron-sufficient (IS, 100 ppm iron), or IF (500 ppm iron) diets and received alcohol (5 g/kg) or isocaloric maltodextrin daily from gestational days (GD) 13.5 to 19.5. Protein and gene expression were quantified in the 6 experimental groups at GD 20.5. RESULTS: PAE did not affect Epo or Bmp6 expression, but reduced p-SMAD1/5/8/SMAD1/5/8 protein ratios in both IS and ID maternal and fetal liver (all p's < 0.01). In contrast, PAE stimulated maternal hepatic expression of Il-6 (p = 0.03) and elevated p-STAT3/STAT3 protein ratios in both IS and ID maternal and fetal liver (all p's < 0.02). PAE modestly elevated maternal Il-1β, Tnf-α, and Ifn-γ. Fetal cytokine responses to PAE were muted compared with dams, and PAE did not affect hepatic Il-6 (p = 0.78) in IS and ID fetuses. Dietary iron fortification sharply attenuated Il-6 expression in response to PAE, with IF driving a 150-fold decrease (p < 0.001) in maternal liver and a 10-fold decrease (p < 0.01) in fetal liver. The IF diet also normalized p-STAT3/STAT3 ratios in both maternal and fetal liver. CONCLUSIONS: These findings suggest that alcohol-driven stimulation of the IL-6/JAK2/STAT3 pathway mediates the elevated hepcidin observed in the PAE dam and fetus. Normalization of these signals by IF suggests that dysregulated hepcidin is driven by alcohol's disruption of the IL-6/JAK2/STAT3 pathway. Prenatal dietary IF represents a potential therapeutic approach for PAE that warrants further investigation.
BACKGROUND: Prenatal alcohol exposure (PAE) causes long-term growth and neurodevelopmental deficits that are worsened by maternal iron deficiency (ID). In our preclinical rat model, PAE causes fetal anemia, brain ID, and elevated hepatic iron via increased maternal and fetal hepcidin synthesis. These changes are normalized by a prenatal iron-fortified (IF) diet. Here, we hypothesize that iron status and PAE dysregulate the major upstream pathways that govern hepcidin production-EPO/BMP6/SMAD and IL-6/JAK2/STAT3. METHODS: Pregnant, Long Evans rat dams consumed ID (2 to 6 ppm iron), iron-sufficient (IS, 100 ppm iron), or IF (500 ppm iron) diets and received alcohol (5 g/kg) or isocaloric maltodextrin daily from gestational days (GD) 13.5 to 19.5. Protein and gene expression were quantified in the 6 experimental groups at GD 20.5. RESULTS:PAE did not affect Epo or Bmp6 expression, but reduced p-SMAD1/5/8/SMAD1/5/8 protein ratios in both IS and ID maternal and fetal liver (all p's < 0.01). In contrast, PAE stimulated maternal hepatic expression of Il-6 (p = 0.03) and elevated p-STAT3/STAT3 protein ratios in both IS and ID maternal and fetal liver (all p's < 0.02). PAE modestly elevated maternal Il-1β, Tnf-α, and Ifn-γ. Fetal cytokine responses to PAE were muted compared with dams, and PAE did not affect hepatic Il-6 (p = 0.78) in IS and ID fetuses. Dietary iron fortification sharply attenuated Il-6 expression in response to PAE, with IF driving a 150-fold decrease (p < 0.001) in maternal liver and a 10-fold decrease (p < 0.01) in fetal liver. The IF diet also normalized p-STAT3/STAT3 ratios in both maternal and fetal liver. CONCLUSIONS: These findings suggest that alcohol-driven stimulation of the IL-6/JAK2/STAT3 pathway mediates the elevated hepcidin observed in the PAE dam and fetus. Normalization of these signals by IF suggests that dysregulated hepcidin is driven by alcohol's disruption of the IL-6/JAK2/STAT3 pathway. Prenatal dietary IF represents a potential therapeutic approach for PAE that warrants further investigation.
Authors: Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer Journal: Clin Chem Date: 2009-02-26 Impact factor: 8.327
Authors: Luís Costa-Matos; Paulo Batista; Nuno Monteiro; Maria Simões; Conceição Egas; Jorge Pereira; Helena Pinho; Natália Santos; João Ribeiro; Maria A Cipriano; Pedro Henriques; Fernando Girão; Alfredo Rodrigues; Armando Carvalho Journal: Eur J Gastroenterol Hepatol Date: 2012-10 Impact factor: 2.566
Authors: Shane M Huebner; Kaylee K Helfrich; Nipun Saini; Sharon E Blohowiak; Adrienne A Cheng; Pamela J Kling; Susan M Smith Journal: Alcohol Clin Exp Res Date: 2018-05-19 Impact factor: 3.455
Authors: Diego Moretti; Jeroen S Goede; Christophe Zeder; Markus Jiskra; Vaiya Chatzinakou; Harold Tjalsma; Alida Melse-Boonstra; Gary Brittenham; Dorine W Swinkels; Michael B Zimmermann Journal: Blood Date: 2015-08-19 Impact factor: 22.113
Authors: Yvonne Kelly; Amanda Sacker; Ron Gray; John Kelly; Dieter Wolke; Maria A Quigley Journal: Int J Epidemiol Date: 2008-10-30 Impact factor: 7.196
Authors: J A Kable; C D Coles; C L Keen; J Y Uriu-Adams; K L Jones; L Yevtushok; Y Kulikovsky; W Wertelecki; T L Pedersen; C D Chambers Journal: Alcohol Date: 2015-09-25 Impact factor: 2.405
Authors: Sze Ting Cecilia Kwan; Camille A Kezer; Kaylee K Helfrich; Nipun Saini; Shane M Huebner; George R Flentke; Pamela J Kling; Susan M Smith Journal: Alcohol Date: 2019-11-14 Impact factor: 2.405
Authors: R Colin Carter; Marjanne Senekal; Christopher P Duggan; Neil C Dodge; Ernesta M Meintjes; Christopher D Molteno; Joseph L Jacobson; Sandra W Jacobson Journal: Am J Clin Nutr Date: 2022-08-04 Impact factor: 8.472
Authors: Kaylee K Helfrich; Nipun Saini; Sze Ting Cecilia Kwan; Olivia C Rivera; Rachel Hodges; Susan M Smith Journal: Nutrients Date: 2022-04-15 Impact factor: 6.706